We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.


Latest Post

March 31, 2017

Preparing for the Future - Compliance with New USP Chapter <381>

<p>It is essential for companies in the pharmaceutical industry to be prepared to comply with compendial changes as soon as they are enacted. USP Chapter &lt;381&gt; (<em>Elastomeric Closure for Injections</em>), which covers West elastomeric components, is scheduled to be reissued on January 1, 2018 as <em>Components Used in Injectable Pharmaceutical Packaging/Delivery Systems</em></p>
Diego Zurbriggen

Diego Zurbriggen

Supervisor, Lab Leachables

Previous Posts
West logo with Diamond

December 29, 2016

West Expands Capabilities in Container Closure Integrity - HVLD

West Pharma

Philomina Albanese

Director, Laboratory Operations


December 21, 2016

West’s Extractables Data Guide    (West EDGe)

West Pharma

Erica Tullo, Ph.D.

Manager, Extractables & Leachables Technology

USP Chapter 1207

July 13, 2016

USP Chapter 1207 Package Integrity Evaluation – Sterile Products

Fran DeGrazio

Fran DeGrazio

VP, Scientific Affairs & Technical Services

Extractabes graphic

May 09, 2016

Extractables and Leachables - Assessing Risk in a Complex Landscape

Lauren Orme

Lauren Orme, PMP

Technical Account Manager

Load more